Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Hematology

Subtypes and Severity: Mapping Your Genetic Profile

At a Glance

Alpha-thalassemia severity depends on how many of your four alpha-globin genes are missing or broken. Subtypes range from asymptomatic silent carriers and mild traits to more severe conditions like Hemoglobin H disease and Hb Bart syndrome.

The severity of alpha-thalassemia is determined by a simple mathematical relationship: the fewer working alpha-globin genes you have, the more severe the condition [1][2]. Because every person normally has four of these genes, the condition is categorized into four distinct subtypes based on how many of those genes are missing or damaged [1][3].

The Four Subtypes of Alpha-Thalassemia

1. Silent Carrier (1 Gene Deletion)

In this state, one alpha-globin gene is missing or non-functional, leaving you with three working genes [1].

  • Symptoms: None. You are clinically healthy and your standard blood tests (like hemoglobin) usually appear normal [1].
  • Diagnosis: Often only discovered through specialized DNA testing, usually when a parent or child is diagnosed with a more severe form [1].

2. Alpha-Thalassemia Trait (2 Gene Deletions)

Also called “Alpha-Thal Minor,” this occurs when two genes are missing, leaving you with two working genes [1][4].

  • Symptoms: Most people are asymptomatic or have very mild anemia (fatigue) [4].
  • Blood Work: Your red blood cells will be smaller (microcytic) and paler (hypochromic) than average [5][6].

3. Hemoglobin H (HbH) Disease (3 Gene Deletions)

With only one working gene remaining, your body struggles to produce enough alpha-globin [1][4].

  • Symptoms: Moderate to severe anemia, fatigue, and potential jaundice (yellowing of the skin/eyes).
  • Management: This is considered a clinical disease state. While many do not need regular transfusions, anemia can worsen during infections or pregnancy [4][5].

4. Hb Bart Syndrome (4 Gene Deletions)

This is the most severe form, where all four alpha-globin genes are missing [7].

  • Impact: Because no alpha-globin is produced, the fetus cannot carry oxygen effectively [7].
  • Outlook: Historically, this was always fatal before or shortly after birth. Today, some babies survive through intrauterine transfusions (transfusions given before birth) and long-term specialized care [8][9].

The “Cis” vs. “Trans” Difference

If you have the Alpha-Thalassemia Trait (2 gene deletions), the way those genes are missing matters immensely for your family planning.

Type Description Common Ancestry Reproductive Risk
Trans (-α/-α) One gene is missing from each chromosome [10]. Often seen in people of African or Mediterranean descent [11]. You cannot pass on two deletions on one chromosome to a child [12].
Cis (–/αα) Both missing genes are on the same chromosome [10]. Frequently seen in people of Southeast Asian descent [11]. If your partner also has a ‘cis’ deletion, there is a 25% risk for the child to have Hb Bart syndrome [11][10].

Deletional vs. Non-Deletional Types

Most cases of alpha-thalassemia are caused by “deletions” (where the gene is physically missing) [1]. However, some people have “non-deletional” mutations, where the gene is present but broken (such as Hb Constant Spring) [2][13]. Generally, non-deletional types result in more severe symptoms and a higher risk of complications than the deletional types with the same number of affected genes [5][13]. DNA testing is the only way to distinguish these differences [14].

Common questions in this guide

What is an alpha-thalassemia silent carrier?
A silent carrier is missing one of the four alpha-globin genes. People with this subtype are clinically healthy, have normal standard blood tests, and usually only discover their status through specialized DNA testing.
What is the difference between alpha-thalassemia cis and trans deletions?
In the 'trans' type, one gene is missing from each chromosome, which limits the risk of passing severe disease to a child. In the 'cis' type, both missing genes are on the same chromosome, which increases the reproductive risk of having a child with a severe subtype.
What are the symptoms of Hemoglobin H (HbH) disease?
Hemoglobin H disease occurs when three alpha-globin genes are missing. It typically causes moderate to severe anemia, fatigue, and sometimes jaundice, and symptoms can worsen during infections or pregnancy.
What does it mean to have a non-deletional alpha-thalassemia mutation?
A non-deletional mutation means the alpha-globin gene is physically present but broken or dysfunctional. These types generally cause more severe symptoms and complications compared to standard deletional types.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain my specific genotype (e.g., --SEA or -α/3.7) and how it affects my symptoms?
  2. 2.If I have HbH disease, is it the 'deletional' or 'non-deletional' type, and does that change my care plan?
  3. 3.Does my subtype put me at risk for iron overload even if I don't receive transfusions?
  4. 4.Should I be monitored by a hematologist who specializes in hemoglobin disorders?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    [Clinical practice guidelines for alpha-thalassemia].

    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Shang X, Zhang X, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):235-242 doi:10.3760/cma.j.issn.1003-9406.2020.03.003.

    PMID: 32128738
  2. 2

    Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

    Lan L, Zheng Z, Wu H

    International journal of general medicine 2025; (18()):7547-7557 doi:10.2147/IJGM.S567328.

    PMID: 41424969
  3. 3

    Rapid detection of α-thalassaemia alleles of --(SEA)/, -α(3.7)/ and -α(4.2)/ using a dual labelling, self-quenching hybridization probe/melting curve analysis.

    Gao L, Liu Y, Sun M, et al.

    Molecular and cellular probes 2015; (29(6)):438-441 doi:10.1016/j.mcp.2015.07.004.

    PMID: 26190814
  4. 4

    The Clinical Phenotypes of Alpha Thalassemia.

    Lal A, Vichinsky E

    Hematology/oncology clinics of North America 2023; (37(2)):327-339 doi:10.1016/j.hoc.2022.12.004.

    PMID: 36907606
  5. 5

    Investigation of the Influence of Deletional and Non-Deletional Hemoglobin H Disease on Pregnancy Outcomes.

    Zhao KS, Pan QA, Yang HY, et al.

    International journal of women's health 2025; (17()):1-7 doi:10.2147/IJWH.S497671.

    PMID: 39802921
  6. 6

    Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia.

    Husna N, Handayani NSN

    Reports of biochemistry & molecular biology 2021; (10(3)):346-353 doi:10.52547/rbmb.10.3.346.

    PMID: 34981010
  7. 7

    Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.

    Amid A, Chen S, Athale U, et al.

    Haematologica 2018; (103(5)):e184-e187 doi:10.3324/haematol.2017.178368.

    PMID: 29371322
  8. 8

    Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis.

    Amid A, Chen S, Brien W, et al.

    Blood 2016; (127(9)):1208-11 doi:10.1182/blood-2015-10-673889.

    PMID: 26732098
  9. 9

    Outcomes and morbidities of patients who survive haemoglobin Bart's hydrops fetalis syndrome: 20-year retrospective review.

    Chan WY, Leung AW, Luk CW, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2018; (24(2)):107-118 doi:10.12809/hkmj176336.

    PMID: 29632273
  10. 10

    Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia.

    King AJ, Higgs DR

    Hematology. American Society of Hematology. Education Program 2018; (2018(1)):353-360 doi:10.1182/asheducation-2018.1.353.

    PMID: 30504332
  11. 11

    Characterization of Hb Bart's Hydrops Fetalis Caused by - -SEA and a Large Novel α0-Thalassemia Deletion.

    He S, Li J, Huang P, et al.

    Hemoglobin 2018; (42(1)):61-64 doi:10.1080/03630269.2018.1434198.

    PMID: 29493331
  12. 12

    A Rare Case of Hemoglobin Bart's Hydrops Fetalis due to Uniparental Disomy of Chromosome 16.

    Tan YR, Tan HK

    Journal of medical cases 2021; (12(7)):275-279 doi:10.14740/jmc3693.

    PMID: 34434471
  13. 13

    Clinical Features and Genotypes of Patients with Hemoglobin H Disease in Taiwan.

    Lin PC, Chang TT, Liao YM, et al.

    Laboratory medicine 2019; (50(2)):168-173 doi:10.1093/labmed/lmy043.

    PMID: 30295867
  14. 14

    Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia?

    Wratsangka R, Tungka EX, Murthi AK, et al.

    Anemia 2024; (2024()):4215439 doi:10.1155/2024/4215439.

    PMID: 38716362

This page explains alpha-thalassemia genetics and subtypes for educational purposes. Always consult a hematologist or genetic counselor to interpret your specific DNA testing results and family planning risks.

Get notified when new evidence is published on Alpha-thalassemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.